Pasadena, California, United States Alexandria Real Estate Equities appeared to be the Corporate Investor, which was created in 1994. The company was established in North America in United States. The main department of described Corporate Investor is located in the Pasadena.
The high activity for fund was in 2017. Despite it in 2019 the fund had an activity. The usual things for fund are deals in the range of 10 - 50 millions dollars. Speaking about the real fund results, this Corporate Investor is 18 percentage points less often commits exit comparing to other organizations. The increased amount of exits for fund were in 2014. The typical startup value when the investment from Alexandria Real Estate Equities is 10-50 millions dollars. Comparing to the other companies, this Alexandria Real Estate Equities performs on 7 percentage points less the average number of lead investments. The fund is constantly included in less than 2 deals per year.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has no specific favorite in a number of founders of portfolio startups. In case when startup counts 5+ of the founder, the chance for it to get the investment is meager. Among the various public portfolio startups of the fund, we may underline KSQ Therapeutics, Cydan, OncoResponse Among the most successful fund investment fields, there are Pharmaceutical, Life Science. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund.
The current fund was established by Joel Marcus. Besides them, we counted 1 critical employee of this fund in our database.
The usual cause for the fund is to invest in rounds with 6-7 partakers. Despite the Alexandria Real Estate Equities, startups are often financed by Polaris Partners, MPM Capital, Amgen Ventures. The meaningful sponsors for the fund in investment in the same round are Versant Ventures, MPM Capital, Polaris Partners. In the next rounds fund is usually obtained by ARCH Venture Partners, Polaris Partners, Amgen Ventures.
Related Funds
Funds with similar focus
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Passkey | 22 Oct 2024 | Cambridge, Massachusetts, United States | |||
TFC Therapeutics | 17 Aug 2023 | Nyack, New York, United States | |||
Stablix | $63M | 03 Jun 2021 | New York, New York, United States | ||
Cradle Genomics | $17M | 16 Jul 2019 | San Diego, California, United States | ||
Strand Therapeutics | $6M | 04 Jun 2019 | Cambridge, Massachusetts, United States | ||
KSQ Therapeutics | $80M | 28 Sep 2018 | Cambridge, Massachusetts, United States | ||
KSQ Therapeutics | $76M | 02 Oct 2017 | Cambridge, Massachusetts, United States | ||
Arbor Biotechnologies | $15M | 01 Jun 2017 | Cambridge, Massachusetts, United States | ||
Frequency Therapeutics | $32M | 11 Apr 2017 | Woburn, Massachusetts, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Passkey | 22 Oct 2024 | Cambridge, Massachusetts, United States | |||
TFC Therapeutics | 17 Aug 2023 | Nyack, New York, United States | |||
Stablix | $63M | 03 Jun 2021 | New York, New York, United States | ||
Cradle Genomics | $17M | 16 Jul 2019 | San Diego, California, United States | ||
Strand Therapeutics | $6M | 04 Jun 2019 | Cambridge, Massachusetts, United States | ||
KSQ Therapeutics | $80M | 28 Sep 2018 | Cambridge, Massachusetts, United States | ||
KSQ Therapeutics | $76M | 02 Oct 2017 | Cambridge, Massachusetts, United States | ||
Arbor Biotechnologies | $15M | 01 Jun 2017 | Cambridge, Massachusetts, United States | ||
Frequency Therapeutics | $32M | 11 Apr 2017 | Woburn, Massachusetts, United States |
